Tecan Group AG - Asset Resilience Ratio
Tecan Group AG (TECN) has an Asset Resilience Ratio of 20.48% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Tecan Group AG (TECN) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how Tecan Group AG's Asset Resilience Ratio has changed over time. See TECN net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Tecan Group AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Tecan Group AG.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF255.66 Million | 13.19% |
| Short-term Investments | CHF141.34 Million | 7.29% |
| Total Liquid Assets | CHF397.00 Million | 20.48% |
Asset Resilience Insights
- Good Liquidity Position: Tecan Group AG maintains a healthy 20.48% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Tecan Group AG Industry Peers by Asset Resilience Ratio
Compare Tecan Group AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Visco Vision Inc.
TW:6782 |
Medical Instruments & Supplies | 0.98% |
|
Daxor Corporation
NASDAQ:DXR |
Medical Instruments & Supplies | 65.10% |
|
GETS Global Bhd
KLSE:5079 |
Medical Instruments & Supplies | 0.03% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Safe Orthopaedics SA
PA:ALSAF |
Medical Instruments & Supplies | 2.20% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
Annual Asset Resilience Ratio for Tecan Group AG (2014–2024)
The table below shows the annual Asset Resilience Ratio data for Tecan Group AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 19.14% | CHF406.01 Million ≈ $513.30 Million |
CHF2.12 Billion ≈ $2.68 Billion |
+1.47pp |
| 2023-12-31 | 17.67% | CHF366.42 Million ≈ $463.26 Million |
CHF2.07 Billion ≈ $2.62 Billion |
+4.09pp |
| 2022-12-31 | 13.57% | CHF293.24 Million ≈ $370.73 Million |
CHF2.16 Billion ≈ $2.73 Billion |
+1.74pp |
| 2021-12-31 | 11.84% | CHF241.91 Million ≈ $305.84 Million |
CHF2.04 Billion ≈ $2.58 Billion |
-29.82pp |
| 2020-12-31 | 41.65% | CHF470.92 Million ≈ $595.37 Million |
CHF1.13 Billion ≈ $1.43 Billion |
+36.28pp |
| 2019-12-31 | 5.37% | CHF50.50 Million ≈ $63.85 Million |
CHF939.77 Million ≈ $1.19 Billion |
+5.26pp |
| 2018-12-31 | 0.11% | CHF977.00K ≈ $1.24 Million |
CHF857.67 Million ≈ $1.08 Billion |
-0.01pp |
| 2017-12-31 | 0.13% | CHF1.02 Million ≈ $1.29 Million |
CHF803.96 Million ≈ $1.02 Billion |
-33.80pp |
| 2016-12-31 | 33.93% | CHF249.78 Million ≈ $315.79 Million |
CHF736.16 Million ≈ $930.71 Million |
+33.73pp |
| 2015-12-31 | 0.20% | CHF1.27 Million ≈ $1.60 Million |
CHF641.48 Million ≈ $811.01 Million |
-0.13pp |
| 2014-12-31 | 0.33% | CHF1.82 Million ≈ $2.31 Million |
CHF552.26 Million ≈ $698.21 Million |
-- |
About Tecan Group AG
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, … Read more